FRETCHIE ANNE C.
LAURO 1BSACCOUNTANCY-A
Complete Accounting Process for Dr. Nick Marasigan, a medical practitioner
JOURNAL
Date ACCOUNT TITLES AND EXPLANATIONS
1 2020
2 1-Oct Cash
3 Marasigan, Capital
4 To record initial investment.
5
6 Medical Building
7 Land
8 20% Notes Payable
9 Cash
10 To record acquired medical clinic and land with issued notes payable and cash pay
11
12 Medical Equipment
13 Medical Supplies
14 24% Notes Payable
15 Cash
16 To record acquired medical equipment and medical supplies with issued notes pay
17
18 2-Oct Prepaid Insurance
19 Cash
20 To record acquired ''all-in-one'' insurance.
21
22 4-Oct Cash
23 Medical Revenues
24 To record received cash from services rendered.
25
26 7-Oct Medical Supplies
27 Accounts Payable
28 To record purchase of medical supplies on account.
29
30 10-Oct Salaries Expense
31 Cash
32 To record paid salaries to the employees.
JOURNAL
Date ACCOUNT TITLES AND EXPLANATIONS
1 2020
2 12-Oct Cash
3 Unearned Research Revenues
4 To record received cash for servie to be rendered.
5
6 18-Oct Accounts Receivable
7 Medical Revenues
8 To record billed patients for services rendered.
9
10 21-Oct Repairs Expense
11 Cash
12 To record payment for repairs of equipment.
13
14 23-Oct Telephone Expense
15 Cash
16 To record payment of the telephone bill.
17
18 24-Oct Medical Equipment
19 Accounts Payable
20 To record purchase of medical equipment on account.
21
22 25-Oct Cash
23 Accounts Receivable
24 To record collection form patients billed on the 18th
25
26 27-Oct Accounts Payable
27 Cash
28 To record payment of account to San Pablo Supply
29
30 30-Oct Marasigan, Withdrawal
31 Cash
32 To record withdrawal.
33
34 Association dues Expense
35 Cash
36 To record payment of dues to Laguna Medical Association
J-1
LANATIONS P.R. DEBIT CREDIT
110 250,000
310 250,000
160 1,000,000
150 250,000
220 1,200,000
110 50,000
ed notes payable and cash payment.
170 420,000
130 39,000
210 400,000
110 59,000
upplies with issued notes payable and cash payment
140 20,000
110 20,000
110 117,000
410 117,000
130 17,000
230 17,000
510 73,000
110 73,000
J-2
LANATIONS P.R. DEBIT CREDIT
110 90,000
260 90,000
120 317,000
410 317,000
220
530 23,000
110 23,000
560 3,000
110 3,000
170 45,000
230 45,000
110 113,000
120 113,000
230 13,000
110 13,000
320 100,000
110 100,000
550 15,000
110 15,000
T-accounts
ASSETS
Cash Cash 110
1-Oct 250,000 50,000 1-Oct
4 117,000 59,000 1
12 90,000 20,000 2
25 113,000 73,000 10
23,000 21
3,000 23
13,000 27
200,000 30
15,000 30
570,000 456,000
114,000
Accounts Receivabl 120
18-Oct 317,000 113,000 27-Oct
204,000
Medical Supplies 130
1-Oct 39,000
7 17,000
56,000
Prepaid Insurance 140
2-Oct 20,000
Land 150
1-Oct 250,000
Medical Building 160
1-Oct 250,000
Medical Equipment 170
1-Oct 420,000
24 45,000
465,000
LIABILITIES
24% Notes Payable 210
400,000 1-Oct
Marasigan, Cap
20% Notes Payable 220
1,200,000 1-Oct
Marasigan, Withdra
30-Oct
Accounts Payable 230
17-Oct 13,000 17,000 7-Oct
45,000 24-Oct
13,000 62,000
49,000
Medical Revenu
Unearned Research Revenue 260 4-Oct
1,200,000 1-Oct 18
Salaries Expen
10-Oct
21-Oct
Association Dues Expen
30-Oct
23-Oct
Dr. Nick Marasigan
OWNER'S EQUITY Trial Balance
For the Month Ended October 2020
Marasigan, Capital 310 Cash
250,000 1-Oct Accounts Receivable
Medical Supplies
Prepaid Insurance
Land
Marasigan, Withdrawal 320 Medical Building
200,000 Medical Equipment
24% Notes Payable
20% Notes Payable
Accounts Payable
Uneraned Research Revenues
Association Dues Expense
INCOME Telephone Expense
Marasigan, Capital
Medical Revenues 410 Marasigan, Withdrawal
117,000 Medical Revenues
317,000 Salaries Expense
434,000 Repairs Expense
TOTAL
EXPENSES
Salaries Expense 510
73,000
Repairs Expense 530
21,000
Association Dues Expense 550
15,000
Telephone Expense 560
3,000
Dr. Nick Marasigan
Trial Balance
onth Ended October 2020
P114,000
204,000
56,000
20,000
250,000
1,000,000
465,000
P400000
1,200,000
49,000
90,000
15,000
3,000
250,000
200,000
434,000
73,000
23,000
2,423,000 2,423,000
ADJUSTMENTS
Date ACCOUNT TITLES P.R. DEBIT
a. 31-Oct Insurance Expense 520 1666.67
Prepaid Insurance 140
b. Supplies Expense 540 35,000
Medical Supplies 130
c. Depreciation Expense- Building 570 5,000
Accumulated Depreciation-Building 165
Depreciation Expense-Equipment 580
Accumulated Depreciation-Equipment 175 9,000
d. Unearned Research Revenues 260 30,000
Research Revenues 420
e. Salaries Expense 510 51,000
Salaries Payable 240
f. Interest Expense 590 28,000
Interest Payable 250
DEBIT CREDIT
1,666.67
35,000
5,000
9,000
30,000
51,000
28,000
DR. NICK MARASIGAN
WORKSHEET
FOR THE MONTH ENDED OCTOBER 2020
TRIAL BALANCE ADJUSTMENTS
ACCOUNT TITLE DEBIT CREDIT DEBIT CREDIT
Cash 114,000
Accounts Receivable 204,000
Medical Supplies 56,000 b 35,000
Prepaid Insurance 20,000 a 1,666.67
Land 250,000
Medical Building 1,000,000
Accumulated Dep. - Medical Bldg. c 5,000
Medical Equipment 465,000
Accumulated Dep. -Medical Equip. c 9,000
24% Notes Payable 400,000
20% Notes Payable 1,200,000
Accounts Payable 49,000
Salaries Payable e 51,000
Interest Payable f 28,000
Unearned Research Revenues 90,000 d 30,000
Marasigan, Capital 250,000
Marasigan, Withdrawal 200,000
Income Summary
Medical Revenues 434,000
Research Revenues d 30,000
Salaries Expense 73,000 e 51,000
Insurance Expense a 1,666.67
Repairs Expense 23,000
Supplies Expense b 35,000
Association Dues Expense 15,000
Telephone Expense 3,000
Depreciation Expense - Bldg c 5,000
Depreciation Expense- Equip. c 9,000
Interest Expense f 28,000
TOTALS P2,423,000 P2,423,000 159,666.67 159,666.67
PROFIT
DEBIT
1,666.67
35,000
5,000
9,000
30,000
51,000
28,000
ARASIGAN
HEET
DED OCTOBER 2020
ADJUSTED TRIAL BALANCE INCOME STATEMENT BALANCE SHEET
DEBIT CREDIT DEBIT CREDIT DEBIT CREDIT
114,000 114,000
204,000 204,000
21,000 21,000
18,333.33 18,333.33
250,000 250,000
1,000,000 1,000,000
5,000 5,000
465,000 465,000
9,000 9,000
400,000 400,000
1,200,000 1,200,000
49,000 49,000
51,000 51,000
28,000 28,000
60,000 60,000
250,000 250,000
200,000 200,000
434,000 434,000
30,000 30,000
124,000 124,000
1,666.67 1,666.67
23,000 23,000
35,000 35,000
15,000 15,000
3,000 3,000
5,000 5,000
9,000 9,000
28,000 28,000
2,516,000 2,516,000.00 243,666.67 P464,000 P2,272,333.33 P2,052,000
220,333.33 220,333.33
P464,000 P464,000 P2,272,333.33 P2,272,333.33
CREDIT
1,666.67
35,000
5,000
9,000
30,000
51,000
28,000
T-accounts for Adjustments
Insurance Expense 520 Depreciation Expense-Bldg.
31-Oct 1,666.67 31-Oct 5,000.00
Prepaid Insurance 140 Accumulated Depreciation-
1,666.67 31-Oct
Supplies Expense 540 Depreciation Expense-Equipment
31-Oct 35,000 31-Oct 35,000
Medical Supplies 130 Accumulated Depreciation- Equipment
35,000 31-Oct
Dr. Nick Marasigan
Adjusted Trial Balance
For the Month Ended October 2020
Cash 114,000
Accounts Receivable 204,000
Medical Supplies 21000
Prepaid Insurance 18,333.33
Land 250,000
Medical Building 1,000,000
Accumulated Dep. - Medical Bldg. 5,000
Medical Equipment 465,000
Accumulated Dep. -Medical Equip. 9,000
24% Notes Payable 400,000
20% Notes Payable 1,200,000
Accounts Payable 49,000
Salaries Payable 51,000
Interest Payable 28,000
Unearned Research Revenues 60,000
Marasigan, Capital 250,000
Marasigan, Withdrawal 200,000
Income Summary
Medical Revenues 434,000
Research Revenues 30,000
Salaries Expense 124,000
Insurance Expense 1,666.67
Repairs Expense 23,000
Supplies Expense 35,000
Association Dues Expense 15,000
Telephone Expense 3,000
Depreciation Expense - Bldg 5,000
Depreciation Expense- Equip. 9,000
Interest Expense 28,000
TOTAL 2,516,000 2,516,000
ation Expense-Bldg. 570 Unearned Research Revenues 260
31-Oct 30,000.00 Interest Expe
31-Oct
Building 165 Research Revenues 420
1,666.67 31-Oct 30,000.00 31-Oct Interest Pa
xpense-Equipment 580 Salaries Expense 510
31-Oct 51,000
preciation- Equipment 175 Salaries Payable 240
35,000 31-Oct 51,000 31-Oct
Dr. Nick Marasigan
Post-Closing Trial Balance
For the Month Ended October 2020
Cash 114,000
Accounts Receivable 204,000
Medical Supplies 21,000
Prepaid Insurance 18,333.33
Land 250,000
Medical Building 1,000,000
Accumulated Dep. - Medical Bldg. 5,000
Medical Equipment 465,000
Accumulated Dep. -Medical Equip. 9,000
24% Notes Payable
20% Notes Payable
Accounts Payable
Salaries Payable
Interest Payable
Unearned Research Revenues
Marasigan, Capital
Marasigan, Withdrawal 200,000
Total P2,272,333.33
Interest Expense 590
28,000.00
Interest Payable 250
28,000.00 31-Oct
400,000
1,200,000
49,000
51,000
28,000
60,000
250,000
P2,272,333.33